Common Serious Side-Effect Of CAR T-Cell Therapy May Be Preventable

CAR T-cells have shown promising results in trials in the treatment of both pediatric and adult leukemia and also certain types of lymphoma. Many researchers hope that with more development, they may eventually be able to replace conventional, toxic chemotherapy regimens for these diseases, but a major stumbling block thus far has been that of CRS a highly dangerous, life-threatening side-effect which affects up to a third of people receiving the therapy.